Get a job referral to Igm Biosciences
California, United States
201-500 Employees
Automotive
•Healthcare
•Tech
Description
IGM Biosciences (NASDAQ: IGMS) is a leading biotechnology company dedicated to developing innovative immunotherapies for the treatment of cancer. Founded in 2010, IGM Biosciences is at the forefront of leveraging cutting-edge technologies to engineer novel IgM antibodies that can target cancer cells with precision. With a focus on advancing next-generation immunotherapies, IGM Biosciences is revolutionizing the field of oncology and striving to improve outcomes for cancer patients worldwide.
Igm Biosciences
Clinical Biomarker Scientist, Immunology (temporary)
Financials
Type
public
Annual Revenue
--
Market Cap
$75.3M+
Subscribe to Refer Me premium to get referred to your dream role at Igm Biosciences!
